Hyperion Therapeutics added to Nasdaq Biotechnology Index
Hyperion Therapeutics announced that it has been selected for addition to the NASDAQ Biotechnology Index®. The semi-annual re-ranking of the NASDAQ Biotechnology Index will become effective upon market open on Dec. 22, 2014. December 18, 2014